Exposing hidden immune vulnerabilities in KRAS-mutant non-small cell lung cancer

The Medical News ·
Health & Medicine United Kingdom

In a series of experiments, researchers have found that an experimental MYC inhibitor drug not only targets lung cancer cells directly but also makes cancer cells easier for the immune system to target and kill.

Read original article on The Medical News →